US2017073661A1PendingUtilityA1
Compositions of enzymes stabilized with stable coenzymes
Est. expiryAug 20, 2029(~3.1 yrs left)· nominal 20-yr term from priority
Inventors:Wolfgang RoedelCarina HornNelli SteinkeNadine BucciThomas MeierRainer SchmuckRolf NagelDieter Heindl
C12N 9/96C12Y 106/99C12Y 101/01001C12Y 101/01047C12Y 101/01002C12Q 1/26C12N 9/0006C12Y 101/01049C12Y 106/05002C12N 9/0036C12Q 1/32C12N 9/0004
49
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods are provided for stabilizing an enzyme by storing the enzyme in the presence of a stabilized coenzyme. In addition, enzymes are provided that are stabilized with a stabilized coenzyme, as well as the use thereof in test elements for detecting analytes. Other aspects include unique compositions, methods, techniques, systems and devices involving enzyme stabilization.
Claims
exact text as granted — not AI-modifiedThe invention claimed is:
1 . A composition, comprising:
an enzyme stabilized with a stabilized coenzyme, wherein the enzyme exhibits a decrease in enzyme activity of less than 50% based on an initial value of enzyme activity when stored for a period of time of at least 2 weeks in an environment that includes at least one of a temperature of at least 20° C. and a presence of light at a wavelength of ≧300 nm, and wherein the enzyme is selected from the group consisting of an alcohol dehydrogenase (EC I.1.1.2), a glucose-6-phosphate dehydrogenase (EC 1.1.1.49) and a diaphorase (EC1.6.99.2).
2 . The composition of claim 1 , wherein the decrease in enzyme activity is less than 30%.
3 . The composition of claim 1 , wherein the decrease in enzyme activity is less than 20%,
4 . The composition of claim 1 , wherein the period of time is at least four weeks.
5 . The composition of claim 1 , wherein the period of time is at least eight weeks.
6 . The composition of claim 1 , wherein the temperature is at least 25° C.
7 . The position of claim 1 , wherein the temperature is at least 30° C.
8 . The composition of claim 1 , wherein the enzyme further exhibits the decrease in enzyme activity of less than 50% when relative air humidity is at least 50%.
9 . The composition of claim 1 , wherein the enzyme further exhibits the decrease in enzyme activity of less than 50% in the absence of desiccants.
10 . The composition of claim 1 , wherein the enzyme further exhibits the decrease in enzyme activity of less than 50% in the absence of desiccants.
11 . The composition of claim 1 , wherein the stabilized coenzyme is one of a stabilized nicotinamide adenine dinucleotide (NAD/NADH) compound, a stabilized nicotinamide adenine dinucleotide phosphate (NADP/NADPH) compound and a compound of formula (I):
12 . The composition of claim 1 , wherein the stabilized coenzyme includes a compound of the general formula (II):
in which
A=adenine or an analogue thereof;
T=in each case independently denotes O or S;
U═in each case independently denotes OH, SH, BH 3 − , or BCNH 2 − ;
V═in each case independently denotes OH or a phosphate group, or two groups which form a cyclic phosphate group;
W═COOR, CON(R) 2 , COR, or CSN(R) 2 in which R in each case independently denotes H or a C 1 -C 2 alkyl;
X 1 , X 2 ═in each case independently denote O, CH 2 , CHCH 3 , C(CH 3 ) 2 , NH, or NCH 3 ;
Y═NH, S, O, or CH 2 ; and
Z═a linear or cyclic organic residue;
provided that Z and the pyridine residue are not linked by a glycosidic bond; or a salt or optionally a reduced form thereof.
13 . The composition of claim 1 , wherein Z is a saturated or unsaturated carbocyclic or heterocyclic 5-membered ring of the general formula (III):
in which
a single or double bond may be present between R 5′ and R 5″ , and where
R 4 ═in each case independently denotes H, F, Cl, or CH 3 ;
R 5 ═CR 4 2 ;
R 5′ ═O, S, NH, NC 1 -C 2 -alkyl, CR 4 , CHOH, or CHOCH 3 , and R 5″ ═CR 4 2 , CHOH, or CHOCH 3 if there is a single bond between R 5′ and R 5″;
R 5′ ═R 5″ ═CR 4 if there is a double bond between R 5′ and R 5″; and
R 6 , R 6′ ═in each case independently denote CH or CCH 3 .
14 . The composition of claim 1 , wherein the stabilized coenzyme includes a compound of the general formula (II):
in which
A=adenine or an analogue thereof;
T=in each case independently denotes O or S;
U═in each case independently denotes OH, SH, BH 3 − , or BCNH 2 − ;
V═in each case independently denotes OH or a phosphate group, or two groups which form a cyclic phosphate group;
W═COOR, CON(R) 2 , COR, or CSN(R) 2 in which R in each case independently denotes H or a C 1 -C 2 alkyl;
X 1 , X 2 ═in each case independently denote O, CH 2 , CHCH 3 , C(CH 3 ) 2 , NH, or NCH 3 ;
Y═NH, S, O, or CH 2 ; and
Z═a linear or cyclic organic residue;
provided that Z and the pyridine residue are not linked by a glycosidic bond; or a salt or optionally a reduced form thereof.
15 . The composition of claim 1 , wherein Z is a saturated or unsaturated carbocyclic or heterocyclic 5-membered ring of the general formula (III):
in which
a single or double bond may be present between R 5′ and R 5″ , and where
R 4 ═in each case independently denotes H, F, Cl, or CH 3 ;
R 5 ═CR 4 2 ;
R 5′ ═O, S, NH, NC 1 -C 2 -alkyl, CR 4 2 , CHOH, or CHOCH 3 , and R 5″ ═CR 4 2 , CHOH, or CHOCH 3 if there is a single bond between R 5′ and R 5″ ;
R 5′ ═R 5″ ═CR 4 if there is a double bond between R 5′ and R 5″ ; and
R 6 , R 6 ′ in each case independently denote CH or CCH 3 .
16 . The composition of claim 1 , wherein the stabilized coenzyme comprises carbaNAD.
17 . The composition of claim 1 , wherein the stabilized coenzyme is a compound of general formula (II):
in which
A=adenine or an analogue thereof;
T=in each case independently denotes O or S;
U═in each case independently denotes OH, SH, BH 3 − , or BCNH 2 − ;
V═in each case independently denotes OH or a phosphate group, or two groups which form a cyclic phosphate group;
W═COOR, CON(R) 2 , COR, or CSN(R) 2 in which R in each case independently denotes H or a C 1 -C 2 alkyl;
X 1 , X 2 ═in each case independently denote O, CH 2 , CHCH 3 , C(CH 3 ) 2 , NH, or NCH 3 ;
Y═NH, S, O, or CH 2 ;
Z═a linear residue with 4-6 C atoms or a saturated or an unsaturated carbocyclic or heterocyclic 5-membered ring of general formula (III):
in which
a single or double bond may be present between R 5′ and R 5″ , and where
R 4 ═in each case independently denotes H, F, Cl, or CH 3 ;
R 5 ═CR 4 2 ;
R 5′ ═O, S, NH, NC 1 -C 2 -alkyl, CR 4 , CHOH, or CHOCH 3 , and R 5″ ═CR 4 2 , CHOH, or CHOCH 3 if there is a single bond between R 5′ and R 5″ ;
R 5′ ═R 5″ ═CR 4 if there is a double bond between R 5′ and R 5″ ; and
R 6 , R 6′ ═in each case independently denote CH or CCH 3 ; and
wherein the Z and the pyridine residue are not linked by a glycosidic bond; or a salt or optionally a reduced form thereof.
18 . A detection reagent for determining an analyte concentration or presence, the detection reagent comprising the composition of claim 1 .
19 . A test element comprising one of the composition of claim 1 and the detection reagent of claim 18 .Join the waitlist — get patent alerts
Track US2017073661A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.